Document is current
Any future updates will be listed below
-
Authors
Adams, Jamie L. http://orcid.org/0000-0002-1170-6688
Dinesh, Karthik http://orcid.org/0000-0001-6042-6079
Snyder, Christopher W.
Xiong, Mulin
Tarolli, Christopher G.
Sharma, Saloni
Dorsey, E. Ray http://orcid.org/0000-0002-5140-1248
Sharma, Gaurav http://orcid.org/0000-0001-9735-9519
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (P50NS108676, P50NS108676, P50NS108676, P50NS108676, P50NS108676, P50NS108676, P50NS108676, P50NS108676)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
- License Information
-
More Information
Article History
Received: 23 December 2020
Accepted: 27 October 2021
First Online: 29 November 2021
Competing interests
: A commercial entity has engaged with the University of Rochester Technology Transfer Office to explore licensing of the analysis algorithms and code associated with this work for deployment on a cloud-based platform. Jamie L. Adams has no conflict of interest to report related to this paper. She received honoraria for speaking at the Huntington Study Group Annual Meeting; received compensation for consulting services from VisualDx; and research support from Azevan Pharmaceuticals, Biogen, Biohaven Pharmaceuticals, Biosensics, Empire Clinical Research Investigator Program, Michael J. Fox Foundation, National Institutes of Health/National Institute of Neurological Disorders and Stroke, NeuroNext Network, Pfizer, and Safra Foundation. Karthik Dinesh has no conflicts of interest related to this paper. He has received research support from MC10. Christopher W. Snyder, Mulin Xiong, and Saloni Sharma have no conflicts of interest to report related to the subject matter or materials discussed in the paper. Christopher G. Tarolli has no conflict of interest to report related to this paper. He has received honoraria for authorship for the American Academy of Neurology; and research support from the American Academy of Neurology Institute, Biosensics, Michael J. Fox Foundation, National Institutes of Health/National Institute of Neurological Disorders and Stroke, and Safra Foundation. E. Ray Dorsey has received honoraria for speaking at American Academy of Neurology courses, American Neurological Association, and University of Michigan; received compensation for consulting services from 23andMe, Abbott, Abbvie, American Well, Biogen, Clintrex, DeciBio, Denali Therapeutics, GlaxoSmithKline, Grand Rounds, Karger, Lundbeck, MC10, MedAvante, Medical-legal services, Mednick Associates, National Institute of Neurological Disorders and Stroke, Olson Research Group, Optio, Prilenia, Putnam Associates, Roche, Sanofi, Shire, Sunovion Pharma, Teva, UCB and Voyager Therapeutics; research support from Abbvie, Acadia Pharmaceuticals, AMC Health, Biosensics, Burroughs Wellcome Fund, Davis Phinney Foundation, Duke University, Food and Drug Administration, GlaxoSmithKline, Greater Rochester Health Foundation, Huntington Study Group, Michael J. Fox Foundation, National Institutes of Health/National Institute of Neurological Disorders and Stroke, National Science Foundation, Nuredis Pharmaceuticals, Patient-Centered Outcomes Research Institute, Pfizer, Prana Biotechnology, Raptor Pharmaceuticals, Roche, Safra Foundation, Teva Pharmaceuticals, University of California Irvine; editorial services for Karger Publications; and ownership interests with Blackfynn (data integration company) and Grand Rounds (second opinion service). Gaurav Sharma has no conflicts of interest related to this paper. He has received research support from MC10.
